Insulet | Umlaufvermögen

Aktienkurs
247.19
Täglich Wechseln
5.30 2.19%
Monatlich
-8.89%
Jährlich
-12.80%
Q1 Prognose
234.39




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
Align Technology USD 2.62B 82.47M 2025-12
AtriCure USD 322.52M 21.41M 2025-12
Avanos Medical USD 351.4M 4.6M 2025-09
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cardinal Health USD 39.23B 693M 2025-12
Cooper Companies USD 2.11B 31.4M 2025-09
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Globus Medical USD 1.92B 194.46M 2025-09
ICU Medical USD 1.19B 16.74M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.14B 754K 2025-09
J&J USD 55.62B 1.01B 2025-12
Masimo USD 1.05B 221.5M 2025-09
Medtronic USD 24B 773M 2025-09
Merit Medical Systems USD 985.53M 62.46M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Solventum Corp USD 4.41B 1.2B 2025-09
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.99B 262.12M 2025-09
West Pharmaceutical Services USD 1.98B 154.9M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12


Insulet Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.